Classifying Dry Eye Disease Patients from Healthy Controls Using Machine Learning and Metabolomics Data
Not on the map. Why?
Abstract (arXiv)
Dry eye disease is a common disorder of the ocular surface, leading patients to seek eye care. Clinical signs and symptoms are currently used to diagnose dry eye disease. Metabolomics, a method for analyzing biological systems, has been found helpful in identifying distinct metabolites in patients and in detecting metabolic profiles that may indicate dry eye disease at early stages. In this study, we explored using machine learning and metabolomics information to identify which cataract patients suffered from dry eye disease. As there is no one-size-fits-all machine learning model for metabolomics data, choosing the most suitable model can significantly affect the quality of predictions and subsequent metabolomics analyses. To address this challenge, we conducted a comparative analysis of nine machine learning models on three metabolomics data sets from cataract patients with and without dry eye disease. The models were evaluated and optimized using nested k-fold cross-validation. To assess the performance of these models, we selected a set of suitable evaluation metrics tailored to the data set's challenges. The logistic regression model overall performed the best, achieving the highest area under the curve score of 0.8378, balanced accuracy of 0.735, Matthew's correlation coefficient of 0.5147, an F1-score of 0.8513, and a specificity of 0.5667. Additionally, following the logistic regression, the XGBoost and Random Forest models also demonstrated good performance.
Key facts. No citing papers in the map yet (data through 7 Oct 2026). Builds on 4 of its 71 references that are in the map. First posted on arXiv 20 Jun 2024.
Builds on
4 of 71 references.
References · 4
- 2016XGBoost: A Scalable Tree Boosting Systemcited by 5,120
- 2021Tabular Data: Deep Learning is Not All You Needcited by 530
- 2020On the training dynamics of deep networks with L2 regularizationcited by 38
- 2021Artificial Intelligence in Dry Eye Diseasecited by 1
Built on by
Not cited yet.